Atacand Tablet
NDC Package 62559-643-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Atacand (candesartan cilexetil) tablets is candesartan is used to treat high blood pressure (hypertension). This formulation utilizes a tablet delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 62559-643 and is authorized under FDA application NDA020838.

Identification & Billing

NDC Package Code
62559-643-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
62559-643
11-Digit Billing Format
62559064390
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Atacand
Non-Proprietary Name
Candesartan Cilexetil
Substance Name
Candesartan Cilexetil
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CANDESARTAN CILEXETIL 32 mg/1
Pharmacologic Class
Usage Information
Candesartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Candesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. This medication is also used to treat heart failure. This medication is not recommended for use in children younger than 1 year due to increased risk of side effects.

Regulatory & Marketing

Labeler Name
Ani Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA020838
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62559-643). Click a package code to view its specific billing and regulatory data.

62559-643-30
30 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62559-643-90 identifies a specific commercial package of 90 tablet in 1 bottle of Atacand, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains candesartan cilexetil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on October 01, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Candesartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Candesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. This medication is also used to treat heart failure. This medication is not recommended for use in children younger than 1 year due to increased risk of side effects.

How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62559064390. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62559-643-90
11-Digit CMS (5-4-2)
62559-0643-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.